{"title":"纳米疗法如何治疗SARS-CoV-2: BI(G)MED经验","authors":"G. Gilbert, Bahi-Jaber Narges","doi":"10.33425/2639-8494.1041","DOIUrl":null,"url":null,"abstract":"While the Sars-CoV-2 epidemics seems to rebound more and more despite the massive vaccination surveys that prove not only moderately efficacy but more deleterious effects than expected, the need for an effective treatment against the coronavirus is imperatively needed. In this article we present such a treatment, based on empirical clinical observations. The goal of this treatment is to give hope to as many patients as possible for the existence of an effective and safe treatment without any side effect.","PeriodicalId":191133,"journal":{"name":"Clinical Immunology & Research","volume":"30 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"How Nanotherapy Fails SARS-CoV-2: The BI(G)MED Experience\",\"authors\":\"G. Gilbert, Bahi-Jaber Narges\",\"doi\":\"10.33425/2639-8494.1041\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"While the Sars-CoV-2 epidemics seems to rebound more and more despite the massive vaccination surveys that prove not only moderately efficacy but more deleterious effects than expected, the need for an effective treatment against the coronavirus is imperatively needed. In this article we present such a treatment, based on empirical clinical observations. The goal of this treatment is to give hope to as many patients as possible for the existence of an effective and safe treatment without any side effect.\",\"PeriodicalId\":191133,\"journal\":{\"name\":\"Clinical Immunology & Research\",\"volume\":\"30 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-12-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Immunology & Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33425/2639-8494.1041\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Immunology & Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33425/2639-8494.1041","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
How Nanotherapy Fails SARS-CoV-2: The BI(G)MED Experience
While the Sars-CoV-2 epidemics seems to rebound more and more despite the massive vaccination surveys that prove not only moderately efficacy but more deleterious effects than expected, the need for an effective treatment against the coronavirus is imperatively needed. In this article we present such a treatment, based on empirical clinical observations. The goal of this treatment is to give hope to as many patients as possible for the existence of an effective and safe treatment without any side effect.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
